Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Home
Profiles
Research units
Research output
Press/Media
Search by expertise, name or affiliation
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
for the GLORIA-AF Investigators
Department of Biomedical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
17
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjusted Hazard Ratio
42%
All-cause Mortality
42%
Apixaban
100%
Atrial Fibrillation
100%
Clinical Practice
100%
Comparative Analysis
14%
Comparative Effectiveness
100%
Comparative Safety
100%
Confidence Interval
14%
Consecutive Patients
14%
Dabigatran
85%
GLORIA
100%
Hazard Ratio
14%
International Registry
14%
Low Risk
14%
Major Bleeding
85%
Myocardial Infarction
42%
New-onset Atrial Fibrillation
28%
Propensity Score Matching
57%
Proportional Hazards Model
14%
Risk of Death
14%
Rivaroxaban
100%
Stroke Risk
28%
Unique Identifier
14%
Vitamin K Antagonists
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antivitamin K
100%
Apixaban
100%
Atrial Fibrillation
100%
Bleeding
85%
Cause of Death
42%
Cerebrovascular Accident
85%
Dabigatran
85%
Heart Infarction
42%
Rivaroxaban
100%